Skip to main content

TEVA Pharmaceutical Industries LTD (TEVA)

Sector
Pharmaceuticals
Last price
$42.62
As of

Kresmion compiles this page from TEVA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-03.

As of . Source: SEC EDGAR filings for TEVA. Method and limitations.

COMPANY DOSSIER

See the full TEVA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for TEVA on one page. Preview it with sample data, then open it live with a free account.

Preview the TEVA dossier

Active events for TEVA

FREE, NO ACCOUNT

Every event on TEVA, as it fires

You are seeing 5 of 13 events recorded on TEVA since 2026-05-30.

The five above landed across 2 days. The other 8 were recorded on 2 other days. 8 of the 13 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, TEVA

More data on TEVA

TEVA against its peers

TEVA's operating margin of 12.5% ranks in the 50th percentile of 16 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.

MetricTEVAPeer medianPercentilen
Revenue FY17.3B USD5.2B USD6722
Gross margin51.8%74.3%1615
Operating margin12.5%10.6%5016
Net margin8.2%12.4%4423
Return on equity17.8%15.4%5223
P / E35.2x20.6x7312
1 year75.3%21.8%7525

Peers (25): ZTS, GSK, VTRS, BMY, JAZZ, PFE, NVO, AZN, NVS, CORT, AXSM, AMRX, MRK, LQDA, AMLX, TARS, OGN, JNJ, BHC, XERS, HRMY, TRVI, LLY, SUPN, ANIP. Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (TEVA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in TEVA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TEVA in the last 180 days.

Upstream: SEC EDGAR filings for TEVA

Kresmion, "TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/TEVA. Upstream data: SEC EDGAR filings for TEVA.

Link to this data (HTML):

<a href="https://kresmion.com/research/TEVA">TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow TEVA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TEVA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the TEVA dossier
Share

The TEVA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.